Kathy Petoumenos

Best Publications

• Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis

  Dorothy A Machalek;Mary Poynten;Fengyi Jin;Christopher K Fairley

  1124
  Citations

• Lipid Profiles in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?

  E Fontas;F van Leth;C A Sabin;N Friis-Møller

  433
  Citations

• Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.

  Jason Grebely;Kathy Petoumenos;Margaret Hellard;Margaret Hellard;Gail V. Matthews;Gail V. Matthews

  249
  Citations

• Rates of cardiovascular disease following smoking cessation in patients with HIV infection: Results from the D:A:D study

  K Petoumenos;S Worm;P Reiss;S de Wit

  228
  Citations

• HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy

  D Lincoln;K Petoumenos;GJ Dore

  199
  Citations

• Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas.

  Janet Knox;Sepehr N Tabrizi;Penny Miller;Kathy Petoumenos

  182
  Citations

• Effective treatment of injecting drug users with recently acquired Hepatitis C virus infection

  Gregory J. Dore;Gregory J. Dore;Margaret Hellard;Margaret Hellard;Gail V. Matthews;Gail V. Matthews;Jason Grebely

  178
  Citations

• Predictors of Hypertension and Changes of Blood Pressure in HIV-Infected Patients:

  Rodolphe Thiebaut;Wafaa El-Sadr;Nina Friis-Møller;Martin M. Rickenbach

  172
  Citations

• Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection.

  Jason Grebely;Son Truong Pham;Gail V. Matthews;Kathy Petoumenos

  134
  Citations

• Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment-Naive, HIV-1–Infected Individuals Commencing cART? A Randomized, Controlled Study

  Alan Winston;Chris Duncombe;Patrick C. K. Li;John M. Gill

  129
  Citations

• Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.

  Hamish McManus;Catherine C. O'Connor;Catherine C. O'Connor;Catherine C. O'Connor;Mark Boyd;Jennifer Broom

  100
  Citations

• Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy.

  Christopher J. Miller;Jason V. Baker;Jason V. Baker;Alison M. Bormann;Kristine M. Erlandson

  98
  Citations

• HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults.

  Nila J Dharan;Paul Yeh;Mark Bloch;Miriam M Yeung;Miriam M Yeung

  96
  Citations

• Plasma interferon‐gamma‐inducible protein‐10 (IP‐10) levels during acute hepatitis C virus infection

  Jason Grebely;Jordan J. Feld;Tanya Applegate;Gail V. Matthews;Gail V. Matthews

  94
  Citations

• Rates of combination antiretroviral treatment change in Australia, 1997-2000.

  K. Petoumenos;D. Austin;D. Baker;M. Block

  90
  Citations

• Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons

  Margalida Rotger;Tracy R. Glass;Thomas Junier;Thomas Junier;Jens Lundgren

  88
  Citations

• HCV reinfection incidence among individuals treated for recent infection.

  Marianne Martinello;Jason Grebely;Kathy Petoumenos;Edward Gane

  87
  Citations

• Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

  Kathy Petoumenos;Signe W. Worm;Eric Fontas;Rainer Weber

  86
  Citations

• Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users

  Jason Grebely;Gail V. Matthews;Gail V. Matthews;Margaret Hellard;Margaret Hellard;David Shaw

  80
  Citations

• Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment - naive, HIV-infected subjects: week 48 data from the Altair study

  Rebekah L. Puls;Preeyaporn Srasuebkul;Kathy Petoumenos;Christoph Boesecke

  79
  Citations